Breaking News

Fresenius Kabi Introduces Leucovorin Calcium Injection, USP

Represents the only liquid presentation of Leucovorin available in the U.S.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Fresenius Kabi’s LeucovorinCalcium Injection, USP, a medication indicated to counteract the toxicity and diminish the effects of impaired methotrexate elimination, is now available in the U.S.   Leucovorin Calcium is also used as a rescue drug after high-dose methotrexate therapy in osteosarcoma, in the treatment of megaloblastic anemia due to folic acid deficiency when oral therapy is not feasible, and in combination with 5-fluorouracil to prolong survival in the palliative treatment of patie...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters